Éric Deutsch

33.7k total citations · 3 hit papers
584 papers, 12.9k citations indexed

About

Éric Deutsch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Éric Deutsch has authored 584 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Oncology, 153 papers in Pulmonary and Respiratory Medicine and 127 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Éric Deutsch's work include Cancer Immunotherapy and Biomarkers (58 papers), Advanced Radiotherapy Techniques (57 papers) and Radiomics and Machine Learning in Medical Imaging (46 papers). Éric Deutsch is often cited by papers focused on Cancer Immunotherapy and Biomarkers (58 papers), Advanced Radiotherapy Techniques (57 papers) and Radiomics and Machine Learning in Medical Imaging (46 papers). Éric Deutsch collaborates with scholars based in France, United States and Austria. Éric Deutsch's co-authors include Cyrus Chargari, Jean Bourhis, Jean‐Charles Soria, Antonin Lévy, Charlotte Robert, Christophe Massard, Laurent Dercle, Roger Sun, Yungan Tao and Antoine Schernberg and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Éric Deutsch

545 papers receiving 12.6k citations

Hit Papers

A radiomics approach to a... 2017 2026 2020 2023 2018 2017 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
    2018 825 citations Roger Sun, Elaine Johanna Limkin et al. profile →
  2. Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
    2017 570 citations Elaine Johanna Limkin, Roger Sun et al. profile →
  3. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
    2021 112 citations Sheela Rao, Marianne G. Guren et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Éric Deutsch 4.3k 3.5k 3.5k 3.0k 1.7k 584 12.9k
Peter E. Huber 3.0k 0.7× 3.1k 0.9× 2.4k 0.7× 3.0k 1.0× 1.7k 1.0× 265 11.5k
C. Norman Coleman 4.7k 1.1× 4.5k 1.3× 3.5k 1.0× 3.1k 1.0× 1.6k 0.9× 256 14.5k
Marek Ancukiewicz 3.3k 0.8× 4.3k 1.2× 1.4k 0.4× 2.4k 0.8× 2.1k 1.2× 127 11.8k
Kevin Camphausen 5.3k 1.2× 3.5k 1.0× 2.5k 0.7× 5.6k 1.9× 829 0.5× 329 14.5k
Rainer Fietkau 3.8k 0.9× 2.1k 0.6× 1.9k 0.5× 1.4k 0.5× 2.6k 1.5× 480 9.9k
Michaël Baumann 4.7k 1.1× 5.2k 1.5× 4.3k 1.2× 4.0k 1.3× 1.2k 0.7× 530 15.4k
Catharine West 3.0k 0.7× 3.3k 0.9× 3.8k 1.1× 5.3k 1.8× 1.5k 0.8× 321 13.3k
Theodore L. DeWeese 2.7k 0.6× 4.1k 1.2× 1.5k 0.4× 3.1k 1.0× 1.1k 0.6× 226 10.0k
Ying Sun 5.4k 1.2× 3.7k 1.1× 2.2k 0.6× 3.6k 1.2× 4.1k 2.4× 404 15.0k
Claus Belka 3.4k 0.8× 6.0k 1.7× 4.7k 1.3× 4.7k 1.6× 1.5k 0.9× 644 16.8k

Countries citing papers authored by Éric Deutsch

Since Specialization
Citations

This map shows the geographic impact of Éric Deutsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Deutsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Deutsch more than expected).

Fields of papers citing papers by Éric Deutsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Deutsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Deutsch. The network helps show where Éric Deutsch may publish in the future.

Co-authorship network of co-authors of Éric Deutsch

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Deutsch. A scholar is included among the top collaborators of Éric Deutsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Deutsch. Éric Deutsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gonnelli, Alessandra, Maria Laura Ermini, Nicolas Signolle, et al.. (2024). Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma. Advanced Materials. 36(28). e2400949–e2400949. 8 indexed citations
2.
Yuste, Claudia, Alexandre Carré, Cristina Veres, et al.. (2023). P13.14.A PREDICTION OF OVERALL SURVIVAL IN HIGH-GRADE GLIOMA USING MULTIPARAMETRIC MRI-BASED RADIOMICS. APPLICATION TO A MULTICENTER COHORT. Neuro-Oncology. 25(Supplement_2). ii104–ii104. 1 indexed citations
3.
Mondini, Michele, Cyrus Chargari, Samy Ammari, et al.. (2023). Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework. Nanomedicine Nanotechnology Biology and Medicine. 50. 102676–102676. 9 indexed citations
4.
Mondini, Michele, Olivier Guipaud, Agnès François, et al.. (2023). Interactions endothélium vasculaire – cellules immunitaires : un point de contrôle clef des lésions digestives radio-induites. Cancer/Radiothérapie. 27(6-7). 643–647. 1 indexed citations
5.
Deutsch, Éric & Lydia Meziani. (2023). Fibrose pulmonaire radio-induite : nouvelles cibles pour demain. Cancer/Radiothérapie. 27(6-7). 491–493. 2 indexed citations
6.
Solier, Stéphanie, Michele Mondini, Lydia Meziani, et al.. (2023). Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues. International Journal of Molecular Sciences. 24(4). 4151–4151. 2 indexed citations
7.
Hamon, Pauline, Marion Classe, Nicolas Signolle, et al.. (2022). TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy. Journal for ImmunoTherapy of Cancer. 10(3). e003519–e003519. 26 indexed citations
8.
Franco, Pierfrancesco, Eva Segelov, Anders Johnsson, et al.. (2022). A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer. Cancers. 14(7). 1697–1697. 10 indexed citations
9.
Sun, Roger, Alexandre Carré, Sophie Bockel, et al.. (2022). Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?. Journal for ImmunoTherapy of Cancer. 10(7). e004848–e004848. 22 indexed citations
10.
Battistella, Enzo, Maria Vakalopoulou, Roger Sun, et al.. (2021). COMBING: Clustering in Oncology for Mathematical and Biological Identification of Novel Gene Signatures. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 19(6). 3317–3331. 3 indexed citations
11.
Yang, Eddy S., Éric Deutsch, Mehmet Altan, et al.. (2021). A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma. Radiotherapy and Oncology. 157. 203–209. 19 indexed citations
12.
Tourneau, Christophe Le, Yungan Tao, Carlos Gomez‐Roca, et al.. (2020). Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 26(24). 6429–6436. 22 indexed citations
13.
Mondini, Michele, Pierre-Louis Loyher, Pauline Hamon, et al.. (2019). CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance. Cancer Immunology Research. 7(3). 376–387. 100 indexed citations
14.
Limkin, Elaine Johanna, Sylvain Reuzé, Alexandre Carré, et al.. (2019). The complexity of tumor shape, spiculatedness, correlates with tumor radiomic shape features. Scientific Reports. 9(1). 4329–4329. 78 indexed citations
15.
Clémenson, Céline, Cyrus Chargari, Michele Mondini, et al.. (2017). The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy. Molecular Cancer Therapeutics. 16(10). 2107–2119. 24 indexed citations
16.
Bonvalot, Sylvie, C. Le Péchoux, Thierry de Baère, et al.. (2016). First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas. Clinical Cancer Research. 23(4). 908–917. 168 indexed citations
17.
Ferté, Charles, Yohann Loriot, Céline Clémenson, et al.. (2013). IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy. Molecular Cancer Therapeutics. 12(7). 1213–1222. 42 indexed citations
18.
Mordant, Pierre, Yohann Loriot, Julien Caldéraro, et al.. (2010). Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination. Molecular Cancer Therapeutics. 9(2). 358–368. 42 indexed citations
19.
Harrington, Kevin J., Iman El‐Hariry, Antoine Lusinchi, et al.. (2009). Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Journal of Clinical Oncology. 27(7). 1100–1107. 52 indexed citations
20.
Prevo, Remko, Éric Deutsch, Oliver Sampson, et al.. (2008). Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity. Cancer Research. 68(14). 5915–5923. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter E. Huber Breakdown of academic impact, for papers by C. Norman Coleman Breakdown of academic impact, for papers by Marek Ancukiewicz Breakdown of academic impact, for papers by Kevin Camphausen Breakdown of academic impact, for papers by Rainer Fietkau Breakdown of academic impact, for papers by Michaël Baumann Breakdown of academic impact, for papers by Catharine West Breakdown of academic impact, for papers by Theodore L. DeWeese Breakdown of academic impact, for papers by Ying Sun Breakdown of academic impact, for papers by Claus Belka
Rankless by CCL
2026